A potential new target for cancer and diabetes: p66Shc adaptor protein suppresses insulin signaling and energy metabolism
2/17/2014

A protein that has been known until recently as part of a complex communication network within the cell also plays a direct role in regulating sugar metabolism, according to a new study published - in the journal Science Signalling (February 18, 2014).Cell growth and metabolism are tightly controlled processes in our cells.

'Smart' gold nanoshells transport cancer drugs
2/17/2014

Nanoparticles capable of delivering drugs to specifically targeted cancer cells have been created by a group of researchers from China.The multifunctional 'smart' gold nanoshells could lead to more effective cancer treatments by overcoming a major limitation of modern chemotherapy techniques - the ability to target cancer cells specifically and leave healthy cells untouched.

A step closer to efficient treatment for cancer-causing herpes
2/17/2014

Herpes virus proteins are more 'spaghetti-like' than previously thought, which provides a vital clue in the search for an efficient treatment against a type of herpes which causes a form of cancer known as Kaposi's sarcoma.

New study reinforces major advantages of Dako's HER2 IQFISH pharmDx in breast cancer diagnostics
2/17/2014

Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics, have announced positive findings in an independent French multicenter study on the performance of Dako's HER2 IQFISH pharmDx(TM).

New study reinforces major advantages of Dako's HER2 IQFISH pharmDx in breast cancer diagnostics
2/17/2014

Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics, have announced positive findings in an independent French multicenter study on the performance of Dako's HER2 IQFISH pharmDx(TM).

Removing Brg1 gene from leukemia stem cells prevented them from dividing, surviving and making new tumors
2/17/2014

A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Universite de Montreal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression. That gene, known as Brg1 is a key regulator of leukemia stem cells that are the root cause of the disease, resistance to treatment and relapse.

'Missing' genetic risk mystery
2/17/2014

A new study could help to answer an important riddle in our understanding of genetics: why research to look for the genetic causes of common diseases has failed to explain more than a fraction of the heritable risk of developing them.

Need for blood donations to maintain platelet supply may be eliminated by new stem cell method
2/17/2014

Platelets, whose primary function is to prevent bleeding, are vital for treating various forms of trauma and blood diseases. However, they can only be obtained through blood donations at present.

Removing Brg1 gene from leukemia stem cells prevented them from dividing, surviving and making new tumors
2/17/2014

A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Universite de Montreal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression. That gene, known as Brg1 is a key regulator of leukemia stem cells that are the root cause of the disease, resistance to treatment and relapse.

Need for blood donations to maintain platelet supply may be eliminated by new stem cell method
2/17/2014

Platelets, whose primary function is to prevent bleeding, are vital for treating various forms of trauma and blood diseases. However, they can only be obtained through blood donations at present.